Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 4
2003 4
2004 6
2005 6
2006 3
2007 6
2008 5
2009 2
2010 5
2011 4
2012 6
2013 3
2014 5
2015 3
2016 4
2017 4
2018 4
2019 3
2020 5
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

79 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean chang yuli kang (2 results)?
Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer.
Kim BS, Kuen DS, Koh CH, Kim HD, Chang SH, Kim S, Jeon YK, Park YJ, Choi G, Kim J, Kang KW, Kim HY, Kang SJ, Hwang S, Shin EC, Kang CY, Dong C, Chung Y. Kim BS, et al. Among authors: kang cy. J Immunother Cancer. 2021 Jun;9(6):e002603. doi: 10.1136/jitc-2021-002603. J Immunother Cancer. 2021. PMID: 34083422 Free PMC article.
Roles of NKT cells in cancer immunotherapy.
Bae EA, Seo H, Kim IK, Jeon I, Kang CY. Bae EA, et al. Among authors: kang cy. Arch Pharm Res. 2019 Jul;42(7):543-548. doi: 10.1007/s12272-019-01139-8. Epub 2019 Mar 11. Arch Pharm Res. 2019. PMID: 30859410 Review.
GITR drives TH9-mediated antitumor immunity.
Kim IK, Chung Y, Kang CY. Kim IK, et al. Among authors: kang cy. Oncoimmunology. 2015 Dec 29;5(5):e1122862. doi: 10.1080/2162402X.2015.1122862. eCollection 2016 May. Oncoimmunology. 2015. PMID: 27467921 Free PMC article.
GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses.
Kim IK, Koh CH, Jeon I, Shin KS, Kang TS, Bae EA, Seo H, Ko HJ, Kim BS, Chung Y, Kang CY. Kim IK, et al. Among authors: kang cy. Cancer Immunol Res. 2019 Mar;7(3):498-509. doi: 10.1158/2326-6066.CIR-18-0518. Epub 2019 Feb 6. Cancer Immunol Res. 2019. PMID: 30728152
79 results